CC6: Metabolic Diseases Flashcards

1
Q

What is the mechanism behind MCAD deficiency? What are the symptoms?

A

MCAD deficiency means you can’t break down fatty acid chains longer than 8 carbons during fasting. Normally, the liver would take up FAs to generate ketones. Without this process, the brain becomes starved of ketones and so keeps using glucose, causing hypoglycemia, coma and eventually death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is clinical presentation of MCAD often seen in the liver?

A

The liver takes up fatty acids during fasting to generate acetyl CoA which is diverted into ketone body synthesis. In MCAD, they can’t break down the fatty acids and so a build up of fatty deposits is often seen in the liver in cases of sudden deaths. Without ketone bodies, the brain is starved and becomes hypoketotic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Jamaican vomiting sickness?

A

This is a disease caused by consuming unripe ackee fruit which poisons a key enzyme in B-oxidation, blocking the pathway. This presents in similar symptoms to MCAD deficiency but at a much faster rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism behind carnitine deficiencies? What are the symptoms?

A

This disease is due to a mutation in the carnitine transporter, preventing FA from being shuttled into the mitochondrial matrix. This results in FAs being stored in other organs, and thickening of the heart chambers because there’s less energy for the heart as well as reduced ketogenesis.

Muscle weakness is due to the muscles eventually requiring FAs to generate ATP, and many show hypoglycemia due to a compensatory shift to glucose metabolism that is to the detriment of the rest of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Zellwegers disease. What are the symptoms?

A

A defect in the import of proteins into the peroxisome, which catalyses the initial steps in oxidation of some FAs, causing hypotonia (poor muscle tone) and seizures, abnormal facial presentations, and usually death within months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the mechanisms and symptoms of Type I von Glerke disease?

A

A deficiency in G-6-Pase (only in the liver ER), resulting in the liver and kidneys becoming enlarged due to excess glycogen that can’t be broken down because G-6-P isn’t active to increase blood glucose from glycogen.

This causes hypoglycemia, and the Cori cycle can’t function so lactate levels rise causing acidification of the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the mechanisms and symptoms behind type III Cori’s disease?

A

A deficiency in the debranching enzyme which removes the branches from glycogen. This causes a build up of abnormal glycogen with lots of short branches that causes damage to organs, especially the liver and muscles.

Difficult to distinguish from type I von Glerke disease by physical examination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the symptoms and mechanisms behind type V McArdle’s disease?

How can this disease be detected?

A

A muscle phosphorylase deficiency which means muscle glycogen can’t be broken down, but blood glucose and liver function isn’t compromised.

This results in enlarged glycogen granules in the muscle, but the muscle can’t then use the glycogen for ATP production in response to exercise, often causing painful cramps and exercise intolerance.

Detected using 31-P magnetic resonance spectroscopy on muscle at rest and during exercise. Individuals with the disease can’t regenerate ATP from ADP in response to acute exercise so there will be a spike in [ADP].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the mechanisms and symptoms behind G-6-P dehydrogenase deficiency

A

Without this enzyme, you cannot produce enough NADPH, which is a source of antioxidant protection. This often only presents due to drugs/infection as these lead to oxidative stress which can’t be overcome. As red blood cells have no other organelle to produce NADPH, but contain high levels of oxygen, they will often burst.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is G-6-P dehydrogenase deficiency related to contraction of malaria?

A

This disease is very common as the distribution of sufferers matches very closely with the distribution of malaria. It’s thought that this deficiency offers a level of protection against malaria due to reduced red blood cells.

As G6PD deficiency leads to increased oxidative stress in red blood cells, this may in turn have a negative influence on the parasite. As such, individuals who possess this mutation have some protection against malaria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms and mechanisms behind PKU disease?

A

A disease where someone is unable to metabolise phenylalanine due to deficiencies in phenylalanine monooxygenase.

If left untreated soon after birth, it causes serious neurological problems, hence why babies are screen within the first 7 days of being born.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the two theories thought to explain the mechanism behind PKU disease

A
  1. Toxic metabolite theory: the new metabolites phenylpyruvate and phenyllactate are responsible, which aren’t normally seen in normal humans. Thus, it’s not actually phenylalanine causing the issue, but it’s the met-metabolites.
  2. Transport hypothesis: phenylalanine at high concentrations outcompetes other molecules for uptake into the brain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is tyrosinemia I disease? How is it treated?

A

A rare autosomal recessive metabolic disorder characterised by the lack of a key enzyme needed to break down tyrosine. This can result in cancer and severe liver disease.

It can be treated with a low tyrosine diet and liver transplantation. A drug is also used that blocks the tyrosine degradation pathway further upstream, as this has less severe liver damage symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why are only some tissues affected by an inborn error?

A
  1. A specific pathway is only active in certain tissues.
  2. Some tissues have higher dependence on a specific fuel that others.
  3. The IEM may affect a tissue-specific isoform of the enzyme.
  4. Some tissues may have less capacity to ‘flex their metabolism’ to a different fuel, or to tolerate the consequences of a restricted pathway.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between catabolic and anabolic?

A

Catabolic: breaking things down for the synthesis of energy
Anabolic: building things up via the synthesis of storage molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the Cori cycle.

A

When glycogen is broken down via glycolysis, the lactate formed during this process diffuses from the muscle into the capillaries and is transported to the liver.

The liver cells oxidise lactate to pyruvate, which may be reconverted to glucose by gluconeogenesis.

This glucose may be exported from the liver and thus made available again to the muscle for energy or storage as glycogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the glucose-alanine cycle (Cahill cycle).

A

Amino groups and lactate from muscle are transported to the liver for gluconeogenesis. The resulting glucose can then be transported back to the muscle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the key molecule involved in cytosolic, and mitochondrial metabolism? List the pathways they are involved in.

A

Cytosolic: G-6-P
- Glycolysis
- Gluconeogenesis
- Pentose phosphate pathway
- Glycogenesis
- Glycogenolysis

Mitochondria: acetyl CoA
- Oxidative phosphorylation
- Ketogenesis
- Ketolysis
- De novo lipogenesis
- Fatty acid oxidation
- Proteolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the Krebs cycle. What is the yield? How is it regulated?

A

Integration of 1 acetyl CoA results in the synthesis of:
- 2 CO2 molecules
- 1 substrate-level phosphorylation (formation of GTP/ATP)
- 4 reduced cofactor molecules (for oxidative phosphorylation)

  1. Feedback inhibition of key enzymes by the products of the reaction to prevent overproduction of ATP and reduced cofactors.
  2. Substrate availability.
  3. Hormones and other signaling molecules e.g., insulin and calcium.
  4. Chronic regulation involves an increased number of mitochondria.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why is calcium used to regulate metabolic pathways, such as the Kreb cycle?

A

Calcium increase signals that there’s an increase in muscle contractility, and hence the muscle is going to require extra energy production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why don’t red blood cells undergo the Krebs cycle or the electron transport chain?

A

They don’t have mitochondria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is glycolysis regulated?

A
  1. Glucose uptake (GLUTs)
  2. Energy state of the cell e.g., PFK1 is inhibited by high ATP levels
  3. Indirect hormone regulation e.g., F-6-P can be converted into F2,6bP which activates PFK1.
  4. Feedforward stimulation e.g., F1,6bP stimulates pyruvate kinase.
  5. Allosteric factors
  6. Covalent modifications - hormonal control
  7. Translocation of proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What’s the difference between GLUT1, GLUT2, and GLUT4?

A

GLUT1: in most tissues, low Km
GLUT2: liver, pancreas; high Km as these will receive a large hit of glucose after eating
GLUT4: insulin-sensitive tissues; induces translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How are glycogenesis and glycogenolysis regulated?

A

These processes involve either glycogen synthase or glycogen phosphorylase. Both are regulated by:
- Adrenaline
- Glucagon (liver only)
- Insulin

GP is also regulated by calcium and AMP in the muscle only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How is gluconeogenesis regulated? How is it tissue specific?

A

+ Glucagon (phosphoenolpyruvate carboxylase, F1,6bP)
- Glucagon (pyruvate kinase)
+ Citrate (F1,6bP)
+ Acetyl CoA (pyruvate carboxylase)

This only occurs in the liver, so G-6-Pase and glucagon receptor expression confers cell specificity to hepatocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How is fatty acid oxidation regulated?

A

Key site of regulation is the carnitine shuttle, as there’s no transporter for fatty acyl CoA so carnitine is added for transport and later removed within the mitochondria.
These shuttles are controlled by malonyl CoA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe de novo lipogenesis. How is it regulated?

A

Takes a non-fatty acid source to generate TAGs by first converting them into acetyl CoA. This generates malonyl CoA which inhibits fatty acid oxidation to prevent futile cycling.

  • Occurs mostly in the liver, but other tissues will still use it to create malonyl CoA for FA oxidation regulation.
  • Acetyl CoA is regulated by palmitoyl CoA, citrate, and energy levels.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe ketolysis and ketogenesis. Where do they occur? How are they regulated?

A

In ketogenesis, TAGs are broken down through the FA oxidation pathway and, within the liver, acetyl CoA is diverted into ketone production rather than into the Krebs cycle. Ketone bodies can then be broken down again to provide acetyl CoA as an alternative fuel source via ketolysis.

Ketogenesis: Liver
Ketolysis: most oxidative tissues

Ketolysis is regulated by substrate availability and ketone body concentration within the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which pathway can amino acids be fed into? How are they used in the fed vs fasted state?

A

Can be fed into different points of the Kreb cycle depending on their carbon skeleton.

Fed state: carbon skeletons are used to make ATP or storage as either TAGs or glycogen.

Fasted state: used by the liver to make either glucose or ketones, depending on the carbon skeleton (i.e., glucogenic or ketogenic, or both).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Which tissues prefer the following substrates for fuel, and why:
- Fatty acids
- Glucose
- Amino acids

A

Fatty acids:
- Heart
- Skeletal muscle
- Liver
- Renal cortex
These have a good oxygen supply, many mitochondria, oxidative metabolism and a high ATP requirement.

Glucose:
- Brain
- RBCs
- Renal medulla
- Skeletal muscle
These have poor oxygen supply and few/no mitochondria (excluding the brain), and are anaerobic.

Amino acids:
- Liver (all except leu, ileu, and val)
- Gut (gln, glu, asp)
- Renal cortex (gln)
- Muscle (leu, ileu, val)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are glucogenic vs ketogenic amino acids?

A

Glucogenic: can be metabolised to produce glucose through gluconeogenesis.

Ketogenic: can be metabolised to produce ketone bodies.

Some amino acids can be both!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Give the pros and cons to fatty acid and glucose metabolism for energy production.

A

FAs:
- More energy rich
- Good for storage
- Needs lots of oxygen

Glucose:
- Less energy rich
- More hydrated, so larger and therefore less desirable as energy storage
- More oxygen efficiency and can generate ATP anaerobically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Why do fats make more energy than glucose?

A

Fats produce far more reduced cofactors that can enter the ETC in B-oxidation, compared to the amount glucose produces in glycolysis and the TCA cycle.

34
Q

What are the advantages and disadvantages of hormonal control of metabolism?

A

+ 1 signal can control multiple tissues
+ 1 signal can control multiple metabolic pathways
+ 1 signal can mediate immediate and delayed responses
- hormones are typically extracellular, so a signaling cascade is required
- intracellular signaling delays the response time

35
Q

How is insulin used in metabolism?

A

Secreted by B cells of the pancreas in the fed state, stimulated by an increase in blood glucose, certain amino acids and certain FAs.

This is a signal of the fed state, stimulating anabolic pathways whilst inhibiting catabolic pathways.

36
Q

Describe the signaling pathway that occurs in B-cells to secrete insulin.

A

The pancreas takes up glucose which enters the B-cells via GLUT2. This triggers glycolysis and increases the [ATP].

Increased [ATP] closes ligand-induced K channels, but opens VG calcium channels. The influx of calcium then causes insulin release.

37
Q

Describe the signaling cascade induced in muscle, adipose, and liver cells by insulin.

A

Insulin binds its receptor and triggers activation of PI3K.
PI3K converts PIP2 into PIP3. PIP3 activates PDK1, activating Akt. Akt then goes on to increase GLUT4 transporters within the membrane for increased glucose uptake.

Insulin also induces activation of enzymes involved in glycolysis.

38
Q

How does insulin stimulate glycogenesis?

A

It activates glycogen synthase whilst inactivating glycogen phosphorylase.

39
Q

How does insulin inhibit fatty acid oxidation?

A

Indirectly, by stimulating the de novo lipogenesis pathway to increase malonyl CoA which inhibits FA oxidation by blocking the carnitine shuttle.

40
Q

How does insulin impact:
- ketogenesis and ketolysis
- protein breakdown
- transcription

A

Decreases ketogenesis and ketolysis
Suppresses protein breakdown
Controls transcription of over 150 genes as there’s multiple insulin TFs.

41
Q

How is glucagon involved in metabolism regulation? How is glucagon release triggered?

A

Glucagon is secreted by the a-cells of the pancreas in the fasted state, simulated by low glucose levels. It only acts on the liver as a signal to liberate glucose into the blood from the liver to fuel other tissues.

In a-cells, low ATP results in calcium influx and inducement of glucagon granule release.

42
Q

How does glucagon impact gluconeogenesis?

A

It activates it, by activating PKA which decreases F-2,6-bP and thus decreases activity of enzymes involved in glycolysis.

It can also increase the synthesis of enzymes involved in gluconeogenesis.

43
Q

How does glucagon regulate glycogenolysis?

A

In the hepatocyte, glucagon activates glycogen phosphorylase whilst inhibiting glycogen synthase to promote glycogenolysis and inhibit glycogenesis.

44
Q

How does glucagon regulate fatty acid oxidation?

A

It increase oxidation by decreasing malonyl CoA levels to upregulate the carnitine shuttle.

Not all of the acetyl CoA made in glycolysis can undergo the Krebs cycle, and so it undergoes ketogenesis.

45
Q

What physiological changes occur in the fasted state? What promotes these changes?

A
  1. Muscle reduces glucose use, so there’s more available for the brain and RBCs.
  2. Muscle increases FA use.
  3. Adipose tissue responds by increasing FA release via lipolysis.

It’s the absence of insulin that promotes these changes, not the increase in glucagon.

46
Q

What is the Randle cycle?

A

The cycle proposes that if fat is most abundant, the cell should stop using glucose to save it for other cells. If glucose is most abundant, the cell should stop using fat.

47
Q

How does insulin regulate lipid metabolism in the fed state?

A

Insulin promotes uptake, storage, and synthesis of lipids in various tissues.

  1. Insulin promotes uptake of non-esterified FAs (NEFAs) from the blood.
  2. Insulin stimulates synthesis of TAGs in adipose tissue.
  3. Insulin promotes TAG storage.
  4. Insulin inhibits NEFA oxidation in muscle and liver tissue by reducing the activity of enzymes involved in B-oxidation e.g., CPT1 and HSL.
48
Q

Compare type I and type II diabetes. How are they diagnosed?

A

Type I: insulin-dependent; typical onset from 1-25 years old due to autoimmune destruction of pancreatic B-cells.

Type II: non-insulin dependent; typical onset >40 years due to insulin resistance in peripheral tissues. Insulin is produced in greater amounts to overcome this, but it can impair insulin secretion from B-cells.

Diagnosis involves monitoring plasma glucose concentrations after a glucose spike.

49
Q

Summarise the metabolic effects of type I diabetes.

A

A lack of insulin means the body thinks it’s starving, promoting catabolism and inhibiting anabolism, but the body is in the fed state.

Changes in blood profile:
- Low insulin
- Hyperglycaemia
- Hyperlipidaemia
- Hyperketonaemic

50
Q

What is diabetic ketoacidosis?

A

Diabetes means that the body constantly thinks it’s in the fasted state due to a lack of insulin.

In an effort to obtain energy from other sources, the body starts to break down fats for fuel, leading to the production of ketones as a byproduct.

High levels of ketones in the blood can can acidify the blood, hence the name ketoacidosis.

51
Q

What are the long-term complications of diabetes?

A

Cardiovascular disease
Nephropathy (kidney disease)
Retinopathy
Neuropathy
Amputation
Depression and dementia
Complications in pregnancy

52
Q

What are the treatment options for type I and type II diabetes?

A

Type I:
- glucose monitoring
- insulin injections
- insulin pumps
- islet transplantation

Type II:
- lifestyle improvements
- drugs e.g., insulin injections or metformin (improves insulin sensitivity)

53
Q

What future treatments are hoped to be used for type I diabetes?

A
  1. Closed circuit loops (sense glucose and automatically infuse the appropriate insulin)
  2. Islet encapsulation advances
  3. Childhood vaccines to prevent diabetes development in high risk individuals
  4. Pancreatic transplantation
54
Q

What mechanisms are thought to drive type II diabetes? What are the metabolic consequences?

A

Peripheral tissue may become resistant to insulin because of:
- adipokines secreted from enlarged adipose tissue
- intracellular lipid accumulation (lipotoxicity)
- high glucose (glucotoxicity)
- adipose-derived hormones

Insulin induces targets but not to the same extent, causing a whole body metabolic shift away from glucose use towards FA use. However, there is still some insulin present so gluconeogenesis and ketogenesis aren’t increased as much as seen in type I.

55
Q

Why do some people argue that diabetes is a fat disease, and not a glucose disease? What 3 mechanisms are driven by intracellular fats?

A

Many metabolic complications of type I diabetes actually stem from excessive rates of FA delivery from adipose to the liver and muscle, due to insulin not being there to inhibit lipolysis, etc.

  1. The Randle cycle - the excess fat drives a decrease in glucose use within cells.
  2. PPARa TF - senses the fat and transcribes genes for fat metabolism and storage.
  3. Lipid-induced insulin resistance - an intermediate in TAG synthesis can prevent insulin signaling, driving insulin resistance.
56
Q

What determines why different tissues have different demands for oxygen?

A

ATP requirements of the tissue
Metabolic preference for aerobic vs anaerobic
Mitochondrial number in the tissue

57
Q

What is hypoxia? Give 2 physiological and 2 pathological examples.

A

A decrease in oxygen concentration.

Physiological: altitude; in utero within the developing foetus.

Pathological: myocardial infarction (restricted blood flow); anaemia (poor oxygen transport)

58
Q

Compare acute and chronic hypoxia.

A

Acute = induces an immediate response via covalent and allosteric mechanism.

Chronic = induces a slower response via transcriptional mechanisms.

A heart attack involves both of these mechanisms i.e., restricted blood flow to the heart over many years, and an acute MI causes sudden vessel blockage.

59
Q

What reaction does adenylate kinase catalyse?

A

ADP + ADP –> ATP + AMP

Acts as an emergency reaction to scavenge energy when there’s low oxygen levels for oxidative phosphorylation (i.e., hypoxia).

60
Q

How is AMPK involved in the response to hypoxia?

A

In response to hypoxia, AMPK is activated by high [AMP] to promote cell survival:
+ stimulates glucose uptake, glycolysis, and glycogenolysis to generate ATP in the absence of oxygen
+ stimulates FA oxidation and uptake
+ stimulates p53 to inhibit the cell cycle and potentially promote autophagy
- decreases anabolic pathways

61
Q

How does AMPK increase glucose uptake? How does this differ to the insulin response, and what does this mean for potential therapies?

A

Phosphorylates the GLUT4 inhibitor, Rab GTPase, allowing for GLUT4 to move to the membrane.

AMPK acts on a different pool of GLUT4 than insulin, so there’s a potential for the insulin GLUT4 to be targeted in diabetes without impacting AMPK signaling.

62
Q

How does AMPK upregulate glycolysis, and what is the fate of pyruvate in hypoxic conditions?

A

Phosphorylates enzymes involved in glycolysis to upregulate them.

Under hypoxic conditions, pyruvate is converted into lactate to provide NAD+. This is the cause of chest pain during a heart attack.

63
Q

How does AMPK increase glycogen breakdown?

A

Inactivates glycogen synthase.

64
Q

How does AMPK reduce de novo lipogenesis and upregulate FA oxidation?

A

Inhibits an enzyme to reduce malonyl CoA concentration, removing inhibition on the carnitine shuttle for FA oxidation.

65
Q

Why is AMPK activation not a long-term solution to acute hypoxia?

A

The heart consumes the most amount of oxygen per gram than any other organ in the body as it requires large amounts of ATP.

This ATP demand is impossible to fulfill in the absence of oxygen, so AMPK is only suitable for very short-term hypoxia.

66
Q

How is hypoxia-inducible factor involved in chronic hypoxia?

A

HIF is a TF that binds to hypoxic response elements that are aimed at ensuring cell survival during hypoxia and restoring normoxia.

In hypoxia, subunit HIF-a escapes normal degradation and moves into the nucleus to bind HIF-B and induce transcription.

It senses decreased oxygen levels by the hydroxylation state of proline residues, as this doesn’t occur in hypoxia and is how HIFa escapes degradation.

67
Q

How does HIF impact metabolism during chronic hypoxia?

A

+ upregulates glycolysis
+ upregulates glycogen content
- inhibits PDH to block oxidative phosphorylation
- reduces FA oxidation as this requires lots of oxygen
- reduces the ETC by reducing complex IV activity

68
Q

How is HIF being looked into for an anaemia treatment?

A

Many pharmaceutical companies are developing compounds that activate HIFa as this can increase RBC numbers (HIFa is trying to improve oxygen transport).

69
Q

What is VO2 max?

A

The maximal aerobic capacity - a measurement of maximum oxygen consumption during physical activity.

70
Q

What are the 3 main energy systems required to meet metabolic demand (i.e., muscle ATP regeneration)?

A
  1. Glycolytic
  2. Mitochondrial respiration
  3. Phosphagen (synthesising ATP from other phosphate products e.g., ADP+ADP)
71
Q

Describe the relationship between substrate utilisation and exercise intensity/duration.

A

Low intensity: relies on fats because there’s time to oxidise them

High intensity: carbohydrates as these are quicker to produce ATP, and it’s easy to access from glycogen stores.

Very high intensity: anaerobic metabolism, causing production of lactate and causes muscle fatigue, and creatine phosphate to quickly produce ATP during short bursts of intense exercise.

72
Q

Why is muscle glycogen a preferred substrate for high-intensity exercise?

A

Carbohydrate metabolism can produce ATP up to three times faster than fat metabolism, which is why carbohydrate availability is crucial for high-intensity exercise.

Glycogen is also stored in the muscles themselves so is closer to the site of energy production.

73
Q

What are the 3 levels of metabolic regulation? Give examples for each.

A
  1. Hormonal
    e.g., insulin and glucagon (and adrenaline)
  2. Allosteric
    e.g., calcium which allosterically activates muscle glycogenolysis following muscle contraction, and activation of glycolysis enzymes.
  3. Substrate-level
    e.g., Randle cycle
74
Q

Describe 2 processes that may lead to increased glycogenolysis during exercise. Which of these is primarily required to meet energetic needs during an all-out sprint?

A
  1. Calcium release via muscle contraction, activating glycogen phosphorylase to increase glycogen breakdown.
  2. Adrenaline release through sympathetic nervous system stimulation, activating glycogen phosphorylase.

Calcium is primarily required for high-intensity exercise, whereas adrenaline is primarily used during moderate-intensity exercise.

75
Q

What is the role of creatine in metabolism?

A

Creatine is stored in the muscle cells as phosphocreatine. During high-intensity exercise, phosphocreatine can donate its phosphate group to ADP to rapidly produce ATP.

76
Q

What is the Warburg effect, and why does it occur?

A

Cancer cells primarily undergo anaerobic glycolysis, producing lactate, even in aerobic conditions.

It is useful to cancer cells because:
1. There’s more ‘carbon’ for the biosynthesis of fatty acids and nucleotides, especially the synthesis of NADPH via PPP. Cancer cells are prone to generating lots of ROS species, so high [NADPH] is important.
2. Lactate accumulation creates a hostile environment to fend off the immune system.

77
Q

How is glutamine addiction achieved through oncogenic signaling?

A

Overexpression of the myc oncogene can lead to glutamine addiction in cancer cells as it upregulates expression of high-affinity glutamine transporters, and other vital enzymes in ‘glutaminolysis’.

78
Q

Why is NADPH important for oxidative stress control?

A

It provides reducing power needed to regenerate antioxidants, such as glutathione and thioredoxin.

79
Q

Which metabolic pathways yield NADPH? Which of these is the main NADPH contributor in cancer cells?

A
  1. PPP
  2. THF pathway to synthesise purine bases (main contributor)
  3. TCA cycle
80
Q

What are oncometabolites and why do these induce cancer?

A

Oncometabolites are metabolites that accumulate in cells due to mutations in genes encoding metabolic enzymes. These can cause metabolic rewiring and epigenetic reprogramming, especially pseudohypoxia (HIFa accumulates).

  • Mutant isocitrate dH leads to accumulation of 2-hydroxyglutarate, although the role of this isn’t completely understood.
  • Succinate dH mutations result in succinate accumulation that can promote angiogenesis.
  • Fumarase mutations results in accumulation of fumarate and a predisposition to renal carcinomas.
81
Q

Is the Warburg effect a cause of cancer, or a result of cancer? How do we know this?

A

Oncogenic signaling causes the Warburg effect.

By adding a radioactive fluorine to glucose molecules, these will get trapped in the cell, so we have observed an increase in glucose uptake in cancer cells compared to WT cells.